Login to Your Account



Clinic Roundup


Monday, November 28, 2011
• Neuralstem Inc., of Rockville, Md., dosed its first patient in a trial of a stem cell therapy in the cervical region of the spine in an ongoing safety trial in amyotrophic lateral sclerosis. The previous 12 patients in the study received stem cell transplants in the lumbar region of the spine, but patient 13 received the transplant in the gray matter of the cervical region.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription